Initio Cell Biyoteknoloji A.Ş.

INITIO CELL develops organ-on-chip devices and assays for precision medicine.

Our products enable pharma/biotech companies transform their drug development via functional rather than descriptive tests.

Unlike existing solutions, our products can determine not only the metastatic potential but also the metastasis sites, creating value for both diagnostics and therapy.

We are looking for funding and B2B.